Uptake Medical Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Uptake Medical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013282
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Uptake Medical Corp (Uptake Med) is a healthcare technology company that develops medical technologies for the treatment of emphysema and lung cancer. The company develops intervapor therapy system, a bronchoscopic procedure in which heated water vapor is delivered to emphysematous lung tissue. Its intervapor system is comprised of three components which include intervapor personalized procedure program (IP3), intervapor catheter and intervapor generator. Uptake Med’s intervapor generator is digitally controlled to precisely produce heated water vapor at specific amounts, temperature and pressure. The company serves hospitals and the healthcare system. Uptake Med is headquartered in Tustin, California, the US.

Uptake Medical Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Uptake Medical Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Uptake Medical Corp, Medical Devices Deals, 2011 to YTD 2017 9
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Uptake Medical Raises Additional USD0.4 Million Financing 11
Uptake Medical Raises USD2 Million Financing 12
Uptake Medical Secures USD40.25 Million in Venture Funding 13
Acquisition 14
Broncus Medical Acquires Uptake Medical 14
Uptake Medical Corp – Key Competitors 15
Uptake Medical Corp – Key Employees 16
Uptake Medical Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Uptake Medical Corp, Pharmaceuticals & Healthcare, Key Facts 2
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Uptake Medical Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Uptake Medical Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Uptake Medical Corp, Medical Devices Deals, 2011 to YTD 2017 9
Uptake Medical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Uptake Medical Raises Additional USD0.4 Million Financing 11
Uptake Medical Raises USD2 Million Financing 12
Uptake Medical Secures USD40.25 Million in Venture Funding 13
Broncus Medical Acquires Uptake Medical 14
Uptake Medical Corp, Key Competitors 15
Uptake Medical Corp, Key Employees 16
Uptake Medical Corp, Other Locations 17

★海外企業調査レポート[Uptake Medical Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EDF Renewables Inc:企業の戦略的SWOT分析
    EDF Renewables Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • AVBOB Mutual Assurance Society:企業の戦略・SWOT・財務分析
    AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report Summary AVBOB Mutual Assurance Society - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bm-Bank Public Joint Stock Company
    Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report Summary Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Grupo Posadas Sab De Cv:企業の戦略・SWOT・財務分析
    Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report Summary Grupo Posadas Sab De Cv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SOCO International plc (SIA):企業の財務・戦略的SWOT分析
    Summary SOCO International Plc (SOCO) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. SOCO produces and supplies natural resources. SOCO h …
  • The National Commercial Bank:企業の戦略・SWOT・財務分析
    The National Commercial Bank - Strategy, SWOT and Corporate Finance Report Summary The National Commercial Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Nanomix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics. The company provides Nanomix system, which is an automated system consisting of a handheld reader and self-contained assay cartridge with a carbon nanotube biosenso …
  • Kuzbasskaya Toplivnaya Company:企業の戦略・SWOT・財務分析
    Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report Summary Kuzbasskaya Toplivnaya Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MTF Biologics:医療機器:M&Aディール及び事業提携情報
    Summary MTF Biologics(MTF) formerly known as Musculoskeletal Transplant Foundation, is a subsidiary of Donor Network West is a medical foundation that offers clinically sound and safe allograft tissue. The foundation offers allograft bone, sports tissue and dermal tissues. Its products include morse …
  • Sahacogen (Chonburi) Public Company Limited (SCG):企業の財務・戦略的SWOT分析
    Sahacogen (Chonburi) Public Company Limited (SCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Global Partners LP:企業の戦略・SWOT・財務情報
    Global Partners LP - Strategy, SWOT and Corporate Finance Report Summary Global Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • State Atomic Energy Corporation Rosatom:企業の戦略的SWOT分析
    State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Southern Co (SO):電力:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Gulfport Energy Corp (GPOR):石油・ガス:M&Aディール及び事業提携情報
    Summary Gulfport Energy Corp (Gulfport) is an oil and gas company that explores, develops and produces oil and natural gas. The company operates its oil and gas exploration and development assets in Utica Shale, West Cote Blanche Bay Field, Hackberry Field, Athabasca, Peace River oil and Cold Lake o …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • BWP Trust:企業の戦略・SWOT・財務情報
    BWP Trust - Strategy, SWOT and Corporate Finance Report Summary BWP Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • EDF Renewables SA:企業の戦略的SWOT分析
    EDF Renewables SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Credit Saison Co., Ltd.
    Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Credit Saison Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Intellia Therapeutics Inc (NTLA):企業の財務・戦略的SWOT分析
    Summary Intellia Therapeutics Inc (Intellia Therapeutics) is a genome editing company that develops proprietary curative therapeutics using CRISPR/Cas9 technology. The company develops in vivo programs for the treatment of liver diseases such as alpha-1 antitrypsin deficiency, hepatitis B infection, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆